• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513740
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976); Appropriate Term/Code Not Available (3191)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/27/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2021 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a 7cm malignant stricture in the esophagus during an upper gastrointestinal stenting procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was tight and was dilated prior to stent placement.During the procedure, the shaft bent while advancing the stent delivery system over the steel wire.The physician attempted to deploy the stent but only 20% of the stent was released from the delivery system.The stent was removed from the patient partially covered by the deployment suture.The procedure was cancelled due to patient's request and opted to have the procedure done in a different facility.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on march 27, 2021 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a 7cm malignant stricture in the esophagus during an upper gastrointestinal stenting procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was tight and was dilated prior to stent placement.During the procedure, the shaft bent while advancing the stent delivery system over the steel wire.The physician attempted to deploy the stent but only 20% of the stent was released from the delivery system.The stent was removed from the patient partially covered by the deployment suture.The procedure was cancelled due to patient's request and opted to have the procedure done in a different facility.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block h6: medical device problem code a27 is being used to capture the reportable issue of aborted/cancelled procedure.Block h10: an ultraflex esophageal stent and delivery system were received for analysis.The stent was received partially deployed.Visual examination of the returned device found that the shaft was kinked approximately 32cm from the tip.No other issues were noted to the stent and delivery system.The reported events of stent partially deployed and shaft kinked were confirmed.Visual examination of the returned device and the media inspection of the photo provided by the complainant showed the shaft was kinked and the stent was partially deployed.It is possible that the factors encountered during the procedure and/or the patient's tight anatomy could have contributed to the kink on the shaft when the physician attempted to deploy the stent.The kink could have caused resistance, limited the performance of the device, contributing to the reported event of stent partial deployment.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to the procedure.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key11697246
MDR Text Key247725399
Report Number3005099803-2021-01772
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716167
UDI-Public08714729716167
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 05/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/25/2022
Device Model NumberM00513740
Device Catalogue Number1374
Device Lot Number0026419537
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/27/2021
Initial Date Manufacturer Received 03/27/2021
Initial Date FDA Received04/20/2021
Supplement Dates Manufacturer Received04/29/2021
Supplement Dates FDA Received05/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age65 YR
Patient Weight58
-
-